ZEAL& Logo (EUIPO, 11/11/2015)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark ZEAL& was filed as Figurative mark on 11/11/2015 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/21/2016.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Dactylographic signs : &, paragraph signs, new line signs #Circles with inscriptions projecting beyond the circumference #More than three circles juxtaposed #Series of letters separated from one another other than by a single space
| Trademark form | Figurative mark |
| File reference | 014784508 |
| Application date | November 11, 2015 |
| Publication date | April 13, 2016 |
| Entry date | July 21, 2016 |
| Expiration date | November 11, 2025 |
Trademark owner
Sydmarken 11
2860 Søborg
DK
2860 Søborg
DK
Trademark representatives
Ceresbyen 75
8000 Aarhus C
DK
goods and services
1
Biomedical compounds, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; peptide substrates used in analyzing and detecting certain toxins for laboratory or research use
5
Pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans and animals including infectious and parasitic diseases, neoplasms, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, mental disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders, pregnancy and childbirth disorders, congenital anomalies, poisoning, communicable diseases, neurological diseases, psychological conditions, inflammatory diseases, reproductive diseases and sexual dysfunction; chemical preparations for medical and pharmaceutical purposes, for the treatment of diseases, illnesses and ailments in humans and animals including infectious and parasitic diseases, neoplasms, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, mental disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders, pregnancy and childbirth disorders, congenital anomalies, poisoning, communicable diseases, neurological diseases, psychological conditions, inflammatory diseases, reproductive diseases and sexual dysfunction; first aid kits; diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseases, illnesses, and ailments in humans and animals including infectious and parasitic diseases, neoplasms, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, mental disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders, pregnancy and childbirth disorders, congenital anomalies, poisoning, communicable diseases, neurological diseases, psychological conditions, inflammatory diseases, reproductive diseases and sexual dysfunction; synthetic peptides for pharmaceutical purposes
35
Retailing of products developed through scientific research and technology, namely, biomedical compounds, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use, pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans and animals including infectious and parasitic diseases, neoplasms, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, mental disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders, pregnancy and childbirth disorders, congenital anomalies, poisoning, communicable diseases, neurological diseases, psychological conditions, inflammatory diseases, reproductive diseases and sexual dysfunction, chemical preparations for medical and pharmaceutical purposes, for the treatment of diseases, illnesses and ailments in humans and animals including infectious and parasitic diseases, neoplasms, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, mental disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders, pregnancy and childbirth disorders, congenital anomalies, poisoning, communicable diseases, neurological diseases, psychological conditions, inflammatory diseases, reproductive diseases and sexual dysfunction, first aid kits, diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseases, illnesses, and ailments in humans and animals including infectious and parasitic diseases, neoplasms, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, mental disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders, pregnancy and childbirth disorders, congenital anomalies, poisoning, communicable diseases, neurological diseases, psychological conditions, inflammatory diseases, reproductive diseases and sexual dysfunction, synthetic peptides for pharmaceutical purposes; promoting collaboration and the exchange of information and resources within the scientific, research and medical communities to achieve advances in the field of health care
42
Scientific and technological services and research and design relating thereto in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; industrial analysis and research services in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; design and development of computer hardware and software; medical, biological, biotechnological, genetic, laboratory and pharmaceutical research, design and development services; design and development of computer hardware and software; medical, biological, biotechnological, genetic and pharmaceutical research, design and development services; laboratory research in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; information and consultancy services relating to all the aforesaid
44
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services; dentistry services; medical analysis for the diagnosis and treatment of persons; pharmaceutical advice
45
Exploitation of IP rights in scientific research and technology by licensing
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| October 8, 2024 | Change Representative, Published | ||
| August 29, 2024 | Change Representative, Published | ||
| January 7, 2021 | Change Representative, Published | ||
| December 16, 2020 | Change Representative, Published | ||
| September 30, 2019 | Transfer / Change of address, Published |
ID: 11014784508